Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Home blood thinner study aims to find easier, cheaper option after major cancer surgery

NCT ID NCT06243510

Summary

This study is comparing two different blood-thinning medications that patients take at home after surgery to remove their bladder for cancer. The goal is to see which drug patients are better at taking consistently, which one they prefer, and what the typical out-of-pocket cost is for each. About 90 patients will be randomly assigned to take either apixaban (a pill) or enoxaparin (an injection) for 30 days after surgery and answer questions about their experience.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

Conditions

Explore the condition pages connected to this study.